Alexis Borisy is of Blueprint Medicines Corp. Currently has a direct ownership of 74,160 shares of BPMC, which is worth approximately $7.52 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 2,242 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.2K
0% 3M change
3.12% 12M change
Total Value Held $7.52 Million

Alexis Borisy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,242 Added 2.93%
74,160 Common Stock
Jun 21 2023
BUY
Grant, award, or other acquisition
-
2,600 Added 3.49%
71,918 Common Stock
Jun 21 2022
BUY
Grant, award, or other acquisition
-
2,600 Added 3.62%
69,318 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,250 Added 3.26%
66,718 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
MGTA
Magenta Therapeutics, Inc. Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
OPK
OPKO HEALTH, INC. Healthcare
TNGX
Tango Therapeutics, Inc. Healthcare
AB

Alexis Borisy

Miami, FL

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC